[1]许振新,代远斌.Cockett综合征合并下肢深静脉血栓形成介入治疗的临床分析[J].医学信息,2021,34(16):81-86.[doi:10.3969/j.issn.1006-1959.2021.16.022]
　XU Zhen-xin,DAI Yuan-bin.Clinical Analysis of Interventional Therapy for Cockett Syndrome Complicated with Deep Vein Thrombosis of Lower Extremities[J].Medical Information,2021,34(16):81-86.[doi:10.3969/j.issn.1006-1959.2021.16.022]
点击复制

Cockett综合征合并下肢深静脉血栓形成介入治疗的临床分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年16期
页码:
81-86
栏目:
论著
出版日期:
2021-08-15

文章信息/Info

Title:
Clinical Analysis of Interventional Therapy for Cockett Syndrome Complicated with Deep Vein Thrombosis of Lower Extremities
文章编号:
1006-1959（2021）16-0081-06
作者:
许振新; 代远斌
（1.重庆医科大学第一临床学院，重庆 400016； 2.重庆医科大学附属第一医院血管外科，重庆 400016）
Author(s):
XU Zhen-xin; DAI Yuan-bin
(1.The First Clinical College of Chongqing Medical University,Chongqing 400016,China; 2.Department of Vascular Surgery,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)
关键词:
Cockett综合征; 髂静脉; 深静脉血栓形成; 介入治疗; 通畅率
Keywords:
Cockett syndrome; Iliac vein; Deep vein thrombosis; Interventional therapy; Patency rate
分类号:
R654.3
DOI:
10.3969/j.issn.1006-1959.2021.16.022
文献标志码:
A
摘要:
目的 观察Cockett综合征合并下肢深静脉血栓形成患者接受腔内治疗的临床疗效，评估其安全性，并探索其综合治疗方案。方法 回顾性分析重庆医科大学附属第一医院血管外科2019年7月~2020年3月收治的39例Cockett综合征合并下肢深静脉血栓形成患者的临床资料，观察患者接受腔内治疗前后下肢周径变化情况、临床症状改善情况、血栓清除情况，随访支架通畅率、静脉通畅率、PTS发生率，评估临床疗效。结果 术后随访6~16个月，所有患者经治疗后下肢肿胀、疼痛症状均明显缓解，溶栓期间无严重出血并发症发生；治疗前后患肢与健肢周径差比较：膝上15 cm术后为（1.17±0.77）cm，小于术前的（8.15±3.31）cm，差异有统计学意义（P＜0.05）；膝下10cm术后为（1.59±1.85）cm，小于术前的（6.45±2.43）cm，差异有统计学意义（P＜0.05）；术后6、9个月支架内总体通畅率均为100.00%，下肢静脉通畅率分别为（81.31±16.09）%、（80.21+17.06）%，深静脉血栓后遗症发生率分别为5.13%、17.95%；术后9个月评估临床疗效，治愈20.51%，好转79.49%。结论 腔内综合治疗安全性可靠，术后短中期静脉通畅率、支架通畅率高，可有效缓解临床症状，降低PTS发生率，整体疗效显著，推荐作为首选治疗方案。
Abstract:
Objective To observe the clinical efficacy of endovascular treatment in patients with Cockett syndrome combined with deep vein thrombosis of the lower extremities, evaluate its safety, and explore its comprehensive treatment plan.Methods A retrospective analysis of the clinical data of 39 patients with Cockett syndrome and deep vein thrombosis of the lower extremities admitted to the Department of Vascular Surgery of the First Affiliated Hospital of Chongqing Medical University from July 2019 to March 2020.Observe the changes in the circumference of the lower limbs, the improvement of clinical symptoms, and the removal of thrombus before and after the patient receives intracavitary treatment.Follow up the stent patency rate, venous patency rate, and PTS incidence to evaluate the clinical efficacy.Results All patients were followed up for 6 to 16 months after treatment. After treatment, the symptoms of lower extremity swelling and pain were significantly relieved, and no serious bleeding complications occurred during thrombolysis;Comparison of the circumference difference between the affected limb and the healthy limb before and after treatment: 15 cm above the knee after operation was (1.17±0.77) cm, which was smaller than the preoperative (8.15±3.31) cm, the difference was statistically significant (P＜0.05);The 10 cm below the knee was (1.59±1.85) cm after surgery, which was smaller than the preoperative (6.45±2.43) cm, the difference was statistically significant (P＜0.05);The overall patency rate in the stent was 100.00% at 6 and 9 months after operation, and the patency rate of the veins of the lower extremities was (81.31±16.09)% and (80.21+17.06)%, respectively.The incidence of sequelae of deep vein thrombosis was 5.13% and 17.95% respectively; the clinical efficacy was evaluated 9 months after the operation,The cure was 20.51% and the improvement was 79.49%.Conclusion The comprehensive intracavitary treatment is safe and reliable, with a high rate of venous patency and stent patency in the short to mid-term postoperative period.It can effectively relieve clinical symptoms and reduce the incidence of PTS. The overall curative effect is significant. It is recommended as the first choice treatment.

参考文献/References:

[1]欧阳林,何平,胡添松,等.髂静脉压迫综合征CT影像解剖基础及分型诊断[J].中华放射学杂志,2016,50(4):274-279. [2]Huang C,Yu G,Huang J.Midterm Results of Endovascular Treatment for Iliac Vein Compression Syndrome from a Single Center[J].Annals of Vascular Surgery,2018(49):57-63. [3]Yin M,Huang X,Cui C,et al.The effect of stent placement for May-Thurner Syndrome combined with symptomatic[J].J Vasc Surg Venous Lymphat Disord,2015,3(2):168-172. [4]Shi WY,Gu JP,Liu CJ,et al.Endovascular treatment for iliac vein compression syndrome with or without lower extremity deep vein thrombosis:A retrospective study on mid-term in stent patency from a single center[J].Eur J Radiol,2016,85(1):7-14. [5]Goldman RE,Arendt VA,Kothary N,et al.Endovascular management of may-thurner syndrome in adolescents:a single center experience[J].J Vasc Interv Radiol,2017,28(1):71-77. [6]张杰,赵亮,王艳阳,等.左髂静脉压迫并发急性髂股静脉血栓形成综合治疗临床分析[J].心肺血管病杂志,2018,11(37):1014-1018. [7]刘恒,刘大伟,刘思洋,等.髂静脉压迫综合征合并下肢深静脉血栓形成的腔内治疗效果评价[J].血管与腔内血管外科杂志,2018,4(4):322-323. [8]徐博,陈以宽.髂静脉压迫综合症合并下肢深静脉血栓形成的腔内治疗[D].重庆:重庆医科大学,2016. [9]张希全,王义平,朱亮,等.下肢深静脉血栓形成腔内治疗的中远期疗效[J].中华普通外科杂志,2014,29(4):265-268. [10]Porter JM,Moneta GL.Reporting standards in venous disease:anupdate.International Consensus Committee on Chronic Venous Dis-ease[J].Journal of Vascular Surgery,1995,21(4):635-645. [11]Villalta S,Bagatella P,Piccioli A,et al.Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome[J].Haemostasis,1994,24(1):158a. [12]Porter JM,Moneta GL.International consensus committee on chronic venous disease.Reporting standards in venous disease:an update[J].Vasc Surg,1995,21(4):635-645. [13]Mahnken AH,Thomson K,de Haan M,et al.CIRSE standards of practice guidelines on iliocaval stenting[J].Cardiovasc Intervent Radiol,2014,37(4):889-897. [14]Carl-Magnus Wahlgren.Endovascular Treatment in Postthrombotic Syndrome[J].Vascular and Endovascular Surgery,2010,44(5):356-360. [15]Khairy SA,Neves RJ,Hartung O,et al.Factors Associated with Contralateral Deep Venous Thrombosis after Iliocaval Venous Stenting[J].European Journal of Vascular and Endovascular Surgery,2017,54(6):745-751. [16]Neglén P,Raju S.Balloon dilation and stenting of chronic iliac vein obstruction:technical aspects and early clinical outcome[J].Journal Of Endovascular Therapy,2000,7(2):79-91. [17]刘军,林瑞敏,陈占,等.利伐沙班联用导管溶栓治疗急性下肢深静脉血栓的疗效及安全性研究[J].中华普外科手术学杂志(电子版),2018,12(6):490-493. [18]余婧,王伟,黄建华,等.美国胸科医师学会第十版静脉血栓栓塞症治疗指南解读[J].中国血管外科杂志(电子版),2016,8(3):228-231. [19]Dunn A.After initial anticoagulation for a first unprovoked venous thromboembolism,aspirin reduced recurrence[J].Ann Intern Med,2015,162(4):JC5. [20]李晓强,张福先,王深明.深静脉血栓形成的诊断和治疗指南(第三版)[J].中国血管外科杂志(电子版),2017,9(4):250-257. [21]王潇.迈之灵联合舒洛地特对下肢深静脉血栓的疗效[J].临床普外科电子杂志,2018,6(1):19-22. [22]汪涛,赵珺,梅家才,等.舒洛地特在下肢深静血栓形成中的治疗效果[J].血管与腔内血管外科杂志,2016,2(4):326-330. [23]《血管与腔内血管外科杂志》编辑部,下肢静脉疾病外科治疗专家协作组.AngioJet机械血栓清除术治疗急性下肢深静脉血栓形成的专家共识(2016版)[J].血管与腔内血管外科杂志,2017,3(1):555-558. [24]高锋利,王克华,苟伟,等.经皮腔内机械药物血栓清除术与导管接触溶栓治疗急性深静脉血栓形成的早期对照研究[J].宁夏医学杂志,2019,41(9):804-806.

相似文献/References:

[1]彭德明.重组人生长激素联合谷氨酰胺治疗严重烧伤患者临床疗效的Meta分析[J].医学信息,2020,33(03):87.[doi:10.3969/j.issn.1006-1959.2020.03.025]
　LI Dan,HUANG Wen,YANG Jing-jie.Analysis of Physical Properties of Different Iliac Vein Stents[J].Medical Information,2020,33(16):87.[doi:10.3969/j.issn.1006-1959.2020.03.025]

更新日期/Last Update: 1900-01-01